Opposing roles for CD34 in B16 melanoma tumor growth alter early stage vasculature and late stage immune cell infiltration.

by Steven Maltby, Spencer Freeman, Matthew J Gold, Jennifer H E Baker, Andrew I Minchinton, Michael R Gold, Calvin D Roskelley, Kelly M McNagny
Published 2011-04-01

Targeting the tumour vasculature: exploitation of low oxygenation and sensitivity to NOS inhibition by treatment with a hypoxic cytotoxin.

by Jennifer H E Baker, Alastair H Kyle, Kirsten L Bartels, Stephen P Methot, Erin J Flanagan, Andrew Balbirnie, Jordan D Cran, Andrew I Minchinton
Published 2013-01-01